Please try another search
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company in the United States. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
Peter K. Sorger | 61 | - | Chairman of Scientific Advisory Board |
Gary L. Crocker | 70 | 2004 | President, Treasurer, Principal Financial Officer, Principal Accounting Officer, CEO & Chairman |
Eric David Andersen | 44 | 2019 | Independent Director |
Douglas A. Lauffenburger | - | - | Member of Scientific Advisory Board |
Josep Tabernero | - | 2018 | Member of Scientific Advisory Board |
Lee N. Newcomer | 69 | 2018 | Member of Scientific Advisory Board |
George Daniel Demetri | 65 | 2017 | Member of Scientific Advisory Board |
Peter Blume-Jensen | - | 2018 | Member of Scientific Advisory Board |
Ana Radeljevic | 42 | 2022 | Independent Director |
Noah Gabriel Levy | 45 | 2019 | Independent Director |
Ulrik B. Nielsen | 51 | 2009 | Co-Founder & Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review